SANDUSKY, Ohio , Feb. 18, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today highlighted the company's anticipated revenue expected this year from its CBD nutraceutical expansion. Earlier this week, the company published an online, multimedia presentation detailing the company's CBD nutraceutical development expansion plans. The presentation includes details on PAOG's strategic engagements with Puration, Inc. (USOTC: PURA), North American Cannabis Holdings, Inc. (USOTC: USMJ) and Alkme Holdings, Inc. (USOTC: ALKM).